Inhibition of VEGF-R2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function

被引：0

作者：

Villalta, S. ^{[1
]}

Lang, Jiena ^{[1
]}

Kubeck, Samantha ^{[1
]}

Kabre, Beniwende ^{[1
]}

Szot, Gregory ^{[1
]}

Calderon, Boris ^{[2
]}

Brekken, Rolf ^{[3
]}

Pullen, Nick ^{[5
]}

Arch, Robert ^{[4
]}

Bluestone, Jeffery ^{[1
]}

机构：

[1] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA

[2] Washington Univ, Dept Pathol & Immunol, Dallas, MO USA

[3] UT Southwestern Med Ctr, Div Surg Oncol, Dallas, TX USA

[4] Pfizer Inc, Pfizer Global Res & Dev, Chesterfield, MO USA

[5] Pfizer Inc, Pfizer Global Res & Dev, Cambridge, MA USA

来源：

JOURNAL OF IMMUNOLOGY | 2013年 / 190卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P5181

引用

页数：1

共 50 条

[31] Exposure to endocrine disruptors accelerates diabetes type 1 development in NOD mice via impaired macrophage function
Bodin, Johanna
Bolling, Anette Kocbach
Becher, Rune
Kuper, Frieke
Lovik, Martinus
Nygaard, Unni Cecilie
TOXICOLOGY LETTERS, 2016, 258 : S25 - S25
[32] Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II
Kudva, YC
Rajagopalan, G
Raju, R
Abraham, RS
Smart, M
Hanson, J
David, CS
HUMAN IMMUNOLOGY, 2002, 63 (11) : 987 - 999
[33] Long Term Effects of Liraglutide and Insulin Treatment on Glucose Tolerance and Islet Morphology in the Early Onset Type 1 Diabetes of NOD Mice
Miuchi, Masayuki
Miyagawa, Jun-ichiro
Konishi, Kosuke
Matsuo, Toshihiro
Kusunoki, Yoshiki
Tokuda, Masaru
Ochi, Fumihiro
Murai, Kazuki
Katsuno, Tomoyuki
Hamaguchi, Tomoya
Namba, Mitsuyoshi
DIABETES, 2012, 61 : A523 - A524
[34] Deletion of 12/15-Lipoxygenase Alters Macrophage and Islet Function in NOD-Alox15null Mice, Leading to Protection against Type 1 Diabetes Development
Green-Mitchell, Shamina M.
Tersey, Sarah A.
Cole, Banumathi K.
Ma, Kaiwen
Kuhn, Norine S.
Cunningham, Tina Duong
Maybee, Nelly A.
Chakrabarti, Swarup K.
McDuffie, Marcia
Taylor-Fishwick, David A.
Mirmira, Raghavendra G.
Nadler, Jerry L.
Morris, Margaret A.
PLOS ONE, 2013, 8 (02):
[35] Role of islet-associated heparan sulfate (HS) proteoglycans and heparanase in type 1 diabetes (T1D) in NOD/Lt mice
Simeonovic, C.
Ziolkowski, A.
Freeman, C.
Parish, C.
ACTA DIABETOLOGICA, 2007, 44 : S48 - S48
[36] Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes
Shimoni, Y
JOURNAL OF PHYSIOLOGY-LONDON, 2001, 537 (01): : 83 - 92
[37] Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice
Parsa, Roham
Andresen, Pernilla
Gillett, Alan
Mia, Sohel
Zhang, Xing-Mei
Mayans, Sofia
Holmberg, Dan
Harris, Robert A.
DIABETES, 2012, 61 (11) : 2881 - 2892
[38] Baicalein Protects against Type 2 Diabetes via Promoting Islet β-Cell Function in Obese Diabetic Mice
Fu, Yu
Luo, Jing
Jia, Zhenquan
Zhen, Wei
Zhou, Kequan
Gilbert, Elizabeth
Liu, Dongmin
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
[39] PD-L1-Driven Tolerance Protects Neurogenin3-Induced Islet Neogenesis to Reverse Established Type 1 Diabetes in NOD Mice
Li, Rongying
Lee, Jeongkyung
Kim, Mi-sun
Liu, Victoria
Moulik, Mousumi
Li, Haiyan
Yi, Qing
Xie, Aini
Chen, Wenhao
Yang, Lina
Li, Yimin
Tsai, Tsung Huang
Oka, Kazuhiro
Chan, Lawrence
Yechoor, Vijay
DIABETES, 2015, 64 (02) : 529 - 540
[40] A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice
Lo Conte, Marta
Cencicchio, Martina Antonini
Ulaszewska, Marynka
Nobili, Angelica
Cosorich, Ilaria
Ferrarese, Roberto
Massimino, Luca
Andolfo, Annapaola
Ungaro, Federica
Mancini, Nicasio
Falcone, Marika
FRONTIERS IN IMMUNOLOGY, 2023, 13

← 1 2 3 4 5 →